| Literature DB >> 22155127 |
Annie Adrait1, Dorothée Lebert, Mathieu Trauchessec, Alain Dupuis, Mathilde Louwagie, Christophe Masselon, Michel Jaquinod, Benoît Chevalier, François Vandenesch, Jérôme Garin, Christophe Bruley, Virginie Brun.
Abstract
Enterotoxin A (SEA) is a staphylococcal virulence factor which is suspected to worsen septic shock prognosis. However, the presence of SEA in the blood of sepsis patients has never been demonstrated. We have developed a mass spectrometry-based assay for the targeted and absolute quantification of SEA in serum. To enhance sensitivity and specificity, we combined an immunoaffinity-based sample preparation with mass spectrometry analysis in the selected reaction monitoring (SRM) mode. Absolute quantification of SEA was performed using the PSAQ™ method (Protein Standard Absolute Quantification), which uses a full-length isotope-labeled SEA as internal standard. The lower limit of detection (LLOD) and lower limit of quantification (LLOQ) were estimated at 352pg/mL and 1057pg/mL, respectively. SEA recovery after immunocapture was determined to be 7.8±1.4%. Therefore, we assumed that less than 1femtomole of each SEA proteotypic peptide was injected on the liquid chromatography column before SRM analysis. From a 6-point titration experiment, quantification accuracy was determined to be 77% and precision at LLOQ was lower than 5%. With this sensitive PSAQ-SRM assay, we expect to contribute to decipher the pathophysiological role of SEA in severe sepsis. This article is part of a Special Issue entitled: Proteomics: The clinical link.Entities:
Mesh:
Substances:
Year: 2011 PMID: 22155127 DOI: 10.1016/j.jprot.2011.11.031
Source DB: PubMed Journal: J Proteomics ISSN: 1874-3919 Impact factor: 4.044